[Non-English content] For English, please click on the interpretation button on the bottom right side of your Zoom application and choose Audio in English. For those listening to the conference call in English, there's an option to mute the original audio in Portuguese by clicking on Mute Original Audio. After the company's presentation, we will begin the questions and answer session. Please send us your name and the company you are representing through the Q&A button at the lower part of the screen. Your name will be called, and your question will then be asked. You will get a request to turn on your microphone, and if you would not like to use it, please write "no microphone" at the end of your question so that we can read it for you. Any statements made during this conference call about the company's business and operational and financial goals are based on the company's assumptions and beliefs and on information currently available. Remarks about the future are not a guarantee of performance. They involve risks and uncertainties and assumptions because they refer to future events, which therefore depend on circumstances that may or may not occur. Investors should understand that the general economic conditions, industry conditions, and other operational factors can affect the company's future performance and lead to results that will differ materially from those expressed in these forward-looking statements. Now, I'd like to invite the executives from Porto to begin their presentation. Hello, good morning, everyone. It's a pleasure to be here with you this morning to present the results for the first quarter of 2026. I have our CFO, Celso Damadi, our Investor Relations Officer, Domingos Falavina, and the CEOs of our verticals and the Head of Porto Asset. We've started this year with a consistent growth trajectory. This is the fifth quarter in a row in which we are expanding by double digits. Our diversification level resulted in over half of our results, being generated by the bank, health, and services verticals. Another highlight was our insurance performance, which grew 48%, keeping its ROE above 30% for the fourth quarter in a row. Our digitalization process has been allowing us to grow in scale and has been essential for the operational efficiency gains that we've had in the last few years. We're doing more with the same assets and adding to the satisfaction level of our clients and brokers. Now let's take a look at our results. This quarter, we reached a total revenue of BRL 11 billion, a growth of 10% versus the first quarter of 2025, with a recurring net income of BRL 958 million, bringing us closer to BRL 1 billion per quarter with a recurring ROAE of 25%. These results were produced by expanding the number of clients and our margins across the company's main businesses. We have about 1 million clients added in the last 12 months, a total of 36.3 million, up 4.5 million. Among all of these indicators, the most relevant is the one promoting all of these goals, which is the company's NPS, which has been sustained at an excellent level, as is our main goal. We are at 86 points during this time. Looking at our verticals, the insurance company had an ROAE of 34%, 11 percentage points higher with a 49% growth in net income. Porto Saúde added 336,000 members, of which 156,000 were in health insurance and 179,000 in dental, a 20% expansion in net income. Porto Bank's revenue went up 24% with an increase of 10% to our net income. In Porto Serviço, we achieved an EBITDA of BRL 101 million, which is 11% lower than the first quarter of 2025, especially because of the investments made in this vertical right now to prepare for the next expansion stage in 2027 and 2028. Our EBITDA margin reached 15%. This quarter, we're also sharing some information here, which is the share in digital customer service as a percentage of the total services we provide to our two main audiences, end customers and brokers. For our customers, we increased the resolution rate by 9 percentage points across all of the services that we provided, and our current level is 72%. For our brokers, which have an even more sophisticated relationship due to the technical complexities involving each of the products and services we provide. We also have grown, reaching 50% of interactions taking place in the digital environment. To give you a little bit of color about these numbers, I'd like to invite Celso Damadi, our CFO, to speak. He's going to continue this presentation. Go ahead, Celso. Thank you. Good morning, everyone. It's a pleasure to be here with you to present our results for the first quarter of 2026. Let us begin with our revenue. We had expressive revenue growth this quarter, up 10%, so a double-digit growth in revenue. One highlight was that Porto Seguro grew 5.5%, and in this revenue growth, we have our [P&C] and life portfolios growing. Auto is growing slightly less, but we have been growing also in our fleet because the risk premium is flat. As Kaki said, our income has grown 49% in the insurance vertical. There's a composition here from inflation that affects our average ticket in Auto, and that is lower. We've had a significant growth in premiums in Auto, and the claims ratio has been lower than we saw in the first quarter of 2025. In Porto Saúde, we had all of those lives that Kaki mentioned with 15% growth in premium. In Porto Bank, our premium grew by 24.5%. In Porto Serviço, it was nearly 1%. We're restructuring Porto Serviço, including our services portfolio, our customers, we eliminated some customers from some contacts that were not as profitable as we would like. We are preparing the company for growth with profitability and income, which is what we always try to do, balance between growth and results. Speaking of results, we had in the previous quarter an ROAE of 23.9%, which was very robust. This quarter, we reached 25% of our recurring ROAE. In Porto Seguro, it represents 34%, this is made up of several portfolios, not only Auto. Auto also improved, but home insurance, we are also leading, transportation and life with reduced loss ratios across nearly all of our insurance products. Our portfolio has been diversified, and all of them have been posting very robust results. Porto Saúde has posted an ROAE of 36%. Our numbers have been growing. We have operational agreements in our contracts, and that has been working very well. These results are quite strong for these two areas. Porto Bank also had an ROAE of 25%. These are very good results for our four business verticals, as none of them are below 23%. Looking at consolidated figures, our ROAE is 25%. When we look at this pro forma, that is, by removing our excess capital due to structural and growth reasons, as we've mentioned before, in order to support the growth we've been having, the, by removing those BRL 3 billion, we would be close to 31%. The returns have been very robust, as they had been in the previous quarter. Now looking at diversification. As Kaki mentioned, in the previous quarter, we had 24% of our net income coming from healthcare, 26% from the Bank, and 7% from Services. Health is very close to 24%. It's dropped to 23%. Bank is at 22%, and Services are at 6%. Insurance is representing 49%. There is a higher share. There used to be a higher share of Auto. With this robust growth in Insurance, fortunately, we have a very diversified and balanced split. Insurance still represents less than half of our net income, which shows that our diversification process is robust. We've had a lot of discipline, fortunately, this quarter, our insurance reached nearly 50%. It truly has been a very good quarter when it comes to returns. Moving on to our financial results. In sum, our financial results had two components that led this quarter's revenue to a lower level than we expected. First was our variable investments, which performed less in Ibovespa versus the CDI, also the interest rate curve with some of the operations that were market marked brought us to this result, BRL 408 million. Our portfolio is mostly in the fixed rate, we have sustained the financial guidance. We'll discuss this soon, we expect it to be sustained. That concludes our presentation, and we'll continue with Dom. Thank you, Celso. Good morning, everyone. Continuing the presentation on the insurance operation, our vertical grew 5.5% with BRL 5.7 billion in premiums. It's important to highlight, especially with our Auto portfolio, that when we looked at the last quarters, the lowest productivity was in the last quarter of 2025, and we've been improving it ever since. We see a 5% growth year-on-year when we adjust for the number of working days. It's a positive trend. All of the portfolios have been growing by double digits. Our loss ratio is very healthy. We've seen reductions across all of our portfolios, 1.6% in Auto, which also has contributed to our growth year-on-year and the ROAE of 34%. This is our 34% ROAE. In Auto, despite an acceleration and a lower contribution from the claims ratio, our growth in P&C and life has made this contribution from Auto and our subscription result to drop. This is another level of diversification in our insurance business. Continuing with Porto Saúde, we added 150,000 lives, a contribution of BRL 2.3 billion in total revenues, and our net income has grown 20%. We saw a growth in premiums and in the number of members. We are changing our product mix right now. The new tickets being added, although they have similar margins or better than the ones in the traditional plans from our older bases, they have a lower average ticket, which means that in this transition period, our premium growth is below the number of members, but this has a lower effect to our margins. In two or three years, we won't see as much of that. From the loss ratio perspective, we had a significant improvement in health insurance individually and also for health and dental insurance together. A quick comment. Yesterday, we had a very relevant launch, a new product in dental insurance, which is called Odontox. It's going to offer dental insurance in combination with Botox application. This is another product that innovates in this vertical. Looking at our results, our ROAE was BRL 215 million in Porto Saúde. Looking at Porto Bank, we've seen a positive growth in revenue, in tariffs, and in credit margins. Our NPS is considered very good, and our net income went up 10%. The bank's efficiency ratio continues to improve. We are at the same level as the main digital banks, near 28%. I'd like to talk a little bit about delinquency or our NPL ratio. We had an increase of nearly 1%, but what I'd like to highlight is that right now we're also seeing our Stage 3 portfolio, and this is how we classify the highest risk potentials. Looking at it from this perspective, we can see that we had already been seeing a deterioration of our portfolio beforehand, and we had been setting provisions for this. Looking at our expectations, our peak was 15.3% in the fourth quarter, and we're starting to see some improvement in this portfolio. A part of it has been provisioned for this quarter as well. Looking at this effect, our ROAE was 25% in Porto Bank with an income of BRL 212 million, up 10% year-on-year. In our services operation, as Kaki mentioned, we are focused on our net promoter score and service quality. It's at around 80 points with nearly 1.5 million services for the last year in home and residence. Looking at digital product revenues, we are growing at 70%, and we're making new partnerships. In the last 12 months, we've had 17 partnerships signed, a total of 73. Income. Here are some of the highlights. Looking at the entire vertical, there was a reduction of 10%, we increased our share of minority participations, making the proportional participation of shareholders go down 1%. There's a second adjustment here. We started to provide amortization of the premium. If we adjusted this to our cash, we would see a growth of 16% for our shareholders year-on-year, not a drop. Our guidance for the year was held except for the effective tax rate. This quarter, we included the operation that we had with Itaú years ago, as a consequence of that, we had an accounting effect of BRL 134 non-cash that was adjusted this quarter. Our guidance is reflecting our accounting numbers, we had to reflect this to take this inclusion into consideration. TJLP is also above our expectations for this year, which will make our interest on our own capital higher, and that also has a slight impact to our effective tax rate. That concludes our presentation, and we can continue with the Q&A. Thank you. We will now begin the questions-and-answer session. If you would like to ask a question, please send your name and the company you are representing through the Q&A button at the lower part of the screen. If you do not want to use your microphone, please write "no microphone" at the end of your question so that we can read it for you. Please hold while we poll for questions. The first question will be asked by Mr. Arnon Shirazi from Citibank. Go ahead, sir. Good morning. Congratulations on these results. I'd like to ask about Porto Bank. We saw a deceleration of the credit portfolio versus the previous quarter. At the same time, we saw an increase in NPL. There was a reduction in Stage 3 assets. Can you give us some color about that? If you can talk a little bit about your asset quality. Thank you. Hi Arnon. Good morning. If you can please repeat that, we couldn't hear it very well on our side. If you don't mind repeating. Of course. Good morning, everyone. My question was about Porto Bank. We saw a reduction in the credit portfolio versus the fourth quarter of 2025 and an increase in your NPL. There was a reduction in the Stage 3 Portfolio percentage. I'd just like to understand those factors better and get an overview of your asset quality. Congratulations on the results. Thank you. We can tell you exactly what we did. A part of our portfolio had already been provisioned for, we posted it at a loss now. This affected our NPL, it didn't affect the Stage 3 because that had already been provisioned for. What we did was a part of our agreements that were up to date and are still up to date, this doesn't affect the remainder, had a provisioned discount. As clients met this agreement, they would receive it, we recognized this from the start now. We posted the loss. This didn't affect us because this already had provisions. We can see this in the Stage 3 graph. There was an impact because you reduced the denominator, so these clients are no longer part of this denominator, so the NPL indicator went up. What's important about this is that in our guidance, we have our full expectations, and we are holding it for 2026. In the previous quarters, we started to focus on the credit card portfolio, which currently has an unfavorable mix. We've been escalating our business in Porto Bank with consortia, car equity, and the card portfolio is still representative. Right now it's under a bit more pressure, but we have made provisions for that, and that's in our guidance. Sorry, we could not understand your question. BRL 900 million. Great. Thank you. The next question will be asked by Mr. Antonio Ruette from Bank of America. Go ahead, sir. Good morning, everyone. Thank you for your time. My question is about your loss ratio. It's been a surprise since the beginning of the year. The loss ratio has been lower than last year, I'd like to understand the moving parts behind this loss ratio. I'd like to understand a bit more about your pricing policy, your frequency, and how this change in mix that we've seen in your portfolio is impacting the loss ratio. How is your frequency changing among the different lines of business? When you look at the loss ratio and also the loss frequency, how will this perform from now on? Are we at an abnormal level? Is this a new frequency level? Thank you. That can be health, mix, or insurance. Which vertical were you referring to? We're seeing the same effect across both, so if you could talk about both, that would be great. Let's start with health. Hi, Antonio. There are two effects here, frequency and severity. It's true our pricing when it comes to new claims are not different in any product lines. Our ambition is to have a final loss ratio. You know, when we price our products, we have to take our maturity into consideration. The price is not created for that initial moment. It's for the long term. This price is adjusted very carefully. We're very detail-oriented about that. The target loss ratio at the end is what we have in our guidance. We see frequencies behaving correctly, as you suggested, going according to our assumptions. Severity has also been at the right level, which is leading to the results you've been seeing. What I want to highlight is that there's a seasonal pattern. The first and the last quarters, typically, not only in the market but also for us, if you look at the last curves before and after the COVID pandemic, show lower loss ratios. The second and third quarters have higher claims ratios. Obviously, this quarter and last quarter doesn't represent the figures for the entire year. Thank you for your question, Antonio. For the insurance company, we have different loss ratios across our portfolios. In Auto, this is 58% and up. Life and residential is above 30%. What we saw this quarter was a reduction in the loss ratio of about 4 points for P&C, and this, it was similar for Auto. In health, we are looking at the loss ratio and modeling it based on frequency and severity, and this affects our subscription and prices. For the rest of the year, we've maintained our guidance. We're focusing on profitability, keeping a good loss ratio, but we're trying to find a good balance with our growth. In general, our loss ratio has been flat across all of our portfolios. Okay, thank you. The next question will be asked by Mr. Tiago Binsfeld from Goldman Sachs. Go ahead, sir. Hi, everyone. Good morning. I have two questions. The first one is for Kakinoff. When we look at the last few years, the company has had top-line growth at around two digits. Where do you expect your marginal growth to come from in the next few years? What are your main growth levers, especially in this scenario that seems to be harder to grow at the top line in Auto and when we're seeing the ba nk and health verticals starting to mature? Will this growth come from new geographies? My second question is for Patricia. Just to continue this rationale, you mentioned the loss ratio, but if you can tell us a little bit more about price, if the company is going to be more aggressive in defending its market share, and if that implies price reductions or any other adjustments to the operation. Thank you. Thank you. Speaking about Auto, we've been seeing a very competitive scenario in Auto. Our sustainable income strategy in this scenario is consistent with what we've always done. Technical discipline to provide the right returns to our investors and shareholders, and at the same time, we're trying to preserve our scale. I can tell you three important things about this when it comes to our expansion. First, the starting point is a strong balance. In 2025 and the first quarter of 2026, we've been seeing high levels of returns in our insurance and Auto, which gives us some more space to find a balance between growth and results. Secondly, we're still having a very big scale. We didn't lose any of our scale in Auto. We are at 6.3 million vehicles insured. It's the biggest fleet we've ever had, which allows us to make analytic changes across all fronts, prices, managing claims. This, with the high scale we have, allows us to continue to grow. The question about how we aim to expand, we have an element which is expanding our portfolio, having a higher offer will allow us to grow. We have premium products. We recently launched a driver app. We don't only want to reduce price, but with this scale of 6.3 million vehicles, we're always trying to find the right price for different client niches to find high profitability. When it comes to pricing, it's more than just reducing prices. It's about having intelligence when you have this level of scale. The third point is that we believe that a consistent value proposition makes a big difference for our customers. An important avenue has been innovation. We recently launched a pro-program called Fifteen Minutes. Our proposal is to reach our clients in up to 15 minutes at night. This program is available in São Paulo, Campinas, Rio de Janeiro, and Salvador. This is also attractive to our customers. In sum, we believe in the company's level of income. We're committed to that. This will allow us to continue growing this year. The main growth avenues are portfolio expansion, intelligent pricing, and an improved value proposition. Tiago, what's guiding our long-term vision is exactly this perspective of sustaining the current growth rates for a considerable amount of time. I'll talk quickly about some of these main avenues, starting with the one that is perceived with the lowest expansion potential that you mentioned, Auto. Auto is representing a very positive cycle. The Auto industry started off strong this year. We're posting single-digit growth levels, but they're between 5% and 10%. Most importantly, this is an under-penetrated industry, contrary to what our market share suggests. We lead this market, and we have a considerable percentage of it. As we implement new products and, as our recent segmentation matures, and as we innovate in services, we see that there's a potential growth that is being captured. This is one of the most developed or most mature parts of the company. This is in general being perceived as the lowest potential part of the company because, well, it's one of the ones that most excites us because of the results and the reaction that we're getting from the market. This is the most important thing. We're always preserving the basic assumption here, which is results quality. We won't hesitate to reduce our growth if this is compromising our ROE because we're at a very healthy level. When we look at the other verticals, of course, I won't go into each one, but in sum, both bank and health have low participation rates in comparison to what we consider to be the fair share in the geographies we act or in the specific segments that we've been working in for the least time. There's car equity, home equity, new products that we've been preparing for launch. We've talked about advancing receivables for corporations and companies in our ecosystem, working capital, and the more traditional products in the bank, as you can see, have been growing at very good rates. We have consortium and, when it comes to services, Porto has the only uniform services structure that covers the entire country. There's a lot of opportunity to expand our partnerships through that B2B2C model. Porto providing services to retailers, car manufacturers, and even insurance companies where we can embed Porto services into their services. In B2C, as we expand the use of these assets, we have 12,000 service providers across Brazil that reduces idleness for the group. Obviously, we don't have linear demand across these clients. The idleness that we are able to take over as we expand the services portfolio will have a double effect. First, it will reduce our D&A significantly due to gains in scale, and obviously they will expand our penetration in number of clients. This is an important entry to the Porto universe. We do see that for the 25%- 30% cycle, we'll have a strong expansion in our customers' portfolio, combined with a higher penetration rate of the products that we have in our preexisting portfolio. We have 1.9 product or service per customer. Four years ago, it was 1.2, and we've been growing at an average speed of 1 decimal point per quarter. These two effects is probably what will sustain our significant growth rates, expanding our top line for the next years. Great. Thank you. The next question will be asked by Mr. Marcelo Mizrahi from Bradesco BBI. Go ahead, sir. Hi, everyone. Thank you for taking my question. I'd like to ask about Porto Bank again. I'd like to understand the write-off adjustment and how that impacts your coverage levels. Stage 3 coverage was a bit below what the company had in the past, and you've been a bit more cautious about this line. My question is about this cost for the future. Do you believe that the risk will be higher than the current level? Would there be any need to go back to Stage 3 or how it was before this quarter? That's the main question for me. When it comes to portfolio growth, have you made the adjustments in underwriting so that you can continue to grow in the next few quarters? Hi. Thank you for your question. Our Stage 3 coverage level, adjusting for the write-off, is stable at 66%. We don't see any changes in our guidance, so this is in our current cost of risk, roughly, increasing 10% of the cost of risk on an equal basis. This is what we had in our guidance. Stage 3, what's happening is we were anticipating that a percentage of our base would be excessively leveraged. This cohort, these older clients are facing challenges in paying. We had anticipated a concern about these clients. That was the reason for this guidance. Stage 3 has gone down. This shows that we're starting to see that the base is being cleaned with this write-off that you mentioned, and that reduces the percentage of the portfolio that has a higher risk of defaulting. Finally, accelerating again, we grew between 14% year-on-year. We don't believe that it's slow. If we continue growing at these levels with higher credit quality, I would not consider this, you know, looking at Brazil as a low level of growth. Sorry. Just to add to what Dom said, our focus among our known customers and the closest customers that we had in our ecosystem remains within our strategy. In the guidance this year, we're demonstrating that. An important point is that for the next periods, and this might happen in 2027 already, we will see a combination of other businesses in credit, and that's going to favor our mix dynamics for credit products. This will make it more comparable to other banks that, and that will be easier. Why is this happening? Our credit portfolio is still dominated by credit cards. For example, we have consigned credit, which is a product that has a low loss ratio, and this makes our mix better balanced and more comparable. We expect to continue growing in products with a higher ROAE, consortia, car, equity. If we use credit cards and the bank account with products that allow us to expand our relationship, this will give us more comparable indicators. For the year, we are sustaining all of our guidance. Sorry, our portfolio growth was 13.7%. With the write-off, our formation was 2.2%, and that was flat versus the previous quarter as well. We expected this to be worse, if I can summarize. Yes, your NPL formation is higher than it was last year. Stage 3 went down, so there was the write-off effect. I don't see any improvement for the future. That's why it wasn't clear for me if, you know, this growth will continue as before. Comparing to your credit portfolio in the first quarter, it dropped more in the previous quarter. I agree that this is at a very good level. Yes. I would not expect it to re-accelerate. We're adapting our guidance. Another important piece of information for you is that you need to look at our revenue versus our expenses versus this formation. Yes, our formation was at BRL 500 millio n, but our provision versus the formation is actually higher, and these provisions are in our guidance. This confirms our vision that, yes, it is higher, but when we looked at our budget, we had already included a margin that would absorb this formation. Okay. Thank you. The next question will be asked by Mr. Kaio Prato from UBS. Good morning. Thank you for taking my question. I have two about insurance specifically. First, I'd like to ask a follow-up question about Auto. You've mentioned a loss of share in this segment. I'd just like to understand if you're starting to see any convergence to the market level, and if you believe you can continue growing in line with the Auto market for this year because we're expecting to see an acceleration for the next quarters. My second question is about efficiency. It's striking that your G&A level is relatively low, about 10% for the first quarter, which is very close to the low end of your guidance. What do you expect for the rest of the year on this line? Was it lower than usual this quarter, or should we even see an upside at efficiency to the guidance? Thank you. Kaio, to answer your question about Auto market share, this year, with the strong balance that we've mentioned, we're trying to find a better balance between growth and results. The first quarter started slower. You saw the numbers from SUSEP, as the quarter progressed, we saw signs of a recovery. In the last quarter of 2025, we remained flat, 0% growth. This quarter, we had 3% growth, we're starting to see a recovery. This importantly happened through the initiatives I mentioned: new products, adjustments in pricing, new partnerships with brokers. Yes, right now, we are trying to find a better balance between the results and our growth for this quarter. We have a high market share, as we've had historically, we know that there are still opportunities to continue growing. We'll continue to address the opportunities that we have so that we can continue growing in Auto. Your second question was about efficiency. We've been making some changes that are appearing in our balance. There's the integration between Porto and Azul that we mentioned in the last quarter, and this led to a consolidation of teams and technology. We've been investing more and more in digitalizing processes and efficiency, and that has led to a better NPS and operational efficiency. Right now, we're within the guidance. We know that we are at peak performance, but we're sustaining this guidance. Efficiency is a very important agenda for an insurance company because it allows us to gain in competitiveness, but we're sustaining the guidance. Thank you, Patricia. The next question was asked by Mr. Ricardo Buchpiguel from BTG Pactual. He asks, "In the health segment, can you give us more details about the competitive scenario? Can you talk about the alternatives for Oncoclínicas, considering the importance of this partner?" He is also asking about Porto Bank, if you could give more details about asset quality and appetite for risk. Should we expect a more challenging macro scenario? Thank you for your question. The competitive scenario continues to be intensive as we saw in the last quarter. The environment didn't change. Speaking about Porto, we've been competing and growing among the four lines that we mentioned. The traditional line, which is about 10%-15% of our sales, and now 90% of our sales is made up of the new product lines, which is providing the results that we mentioned with lower average tickets, which reflect on a good loss ratio, and this impacts the premiums, as we mentioned. It's a very competitive market. Since last year, we launched a pro products in Vale, ABC Region. Recently, it was launched in Ribeirão Preto, Piracicaba, Sorocaba. We've been expanding our work, and we're always technical about what we do with prices that reflect the appropriate seasons in our risk appetite. You also asked about Oncoclínicas. As you know, they are an important partner in outpatient oncology. Among the entire hospital environment, we separated into a hospital and outpatient. It's important to see that so that we don't overestimate or underestimate the effects and impact. That's important. We've been working together with Oncoclínicas, but also other partners. The volume from Oncoclínicas is very relevant. On the short term, we don't see a complete rupture from the traditional environment. We continue to be partners with our clients there. Yes, we are active in speaking to other partners that would like to partner with us if Oncoclínicas stops providing services. The impact when it comes to losses is possible on the short term and the medium term. Finding a good landing solution would be good because we've been contacted by several potential partners. If this happens, we might have some impact, but that would be mitigated, I would say, completely with this landing solution with another partner or with diversifying partners. Speaking about Porto Bank, since the second quarter of 2025, we've had a process in which we are being more selective in our clients. We've been reducing the number of clients that may have a higher complication in their spending and consumption profile. This has been provoked by the macroeconomic scenario, as you mentioned. Our indicators and our guidance has already included a more challenging scenario. We've been focusing on expanding products like consortium and car equity. We're trying to find a balance so that we can deliver the results that we committed to. When it comes to credit, yes, we do have a more challenging scenario, but we had foreseen this in our guidance, and this has been posted in the numbers that we presented. The next question will be asked by Mr. Guilherme Grespan from JP Morgan. Go ahead, sir. Hi, everyone. Good morning. Thank you. I have a simple question, and I apologize for insisting on this, but it's about Auto. Running the numbers for the quarter, if you take what was published by SUSEP before January and February, it was at around 56%, 57%. Obviously, the calendar helps, but you were close to 58%. If you run the numbers, that means that March was close to 64%. I know that there is a calendar effect in March as well. My question is: Can we extrapolate this as your strategy in Porto of having a loss ratio that was higher for auto throughout the year but a stronger growth closer to the top of the guidance? Is March only a calendar effect, maybe, due to January and February? Guilherme, there is a calendar effect in March. In the first quarter, when we look at January and February, we have three fewer working days that were offset in March. We don't really see higher loss ratios above what we expected. This remains within our expectations. Again, we're always pursuing a higher balance between growth and results, but we're doing it very cautiously, very carefully. This is mostly due to the number of working days. This is not our pricing strategy that's increasing our loss ratio. Hi, Guilherme Grespan, this is Celso Damadi. The same effect that you mentioned will be seen in SUSEP data when you look at premiums. The number of working days in March, we had a robust level of growth for several reasons, like Patricia said, price, utilization, and so on, but the number of working days. Since we had Carnival in February this year, we had a higher number of holidays, and customers were then less exposed to risk. Losses are higher on average in frequency and severity in working days. That's why March is not a good proxy for the year. We're sustaining our proxy. You know, January and February would also not work as a proxy for the rest of the year. If it's important to look at it on a quarterly basis and compare it to similar quarters, because then you have a better comparison. What we would recommend here would be to look at the quarter and not at isolated months. Adding to that, since your question mentioned competitiveness, I can share what our strategy is for this year. Our gains are conditioned to efficiency and reducing DA. This is what we've celebrated this first quarter, not only in Auto, but throughout the entire organization. As the company continues to grow, all of the verticals are benefiting from this gain in scale and an increasingly competitive DA. Specifically for Auto and insurance, we're consistent in one-digit growth. This has also led to important competitiveness gains in pricing. It's not a part of our culture to have a higher appetite for loss ratios. We try to be more competitive. That's why we have this guidance for the year, and we're continuing to work on digitalization, scale gains, and expanding our global client space. Great. Thank you, everyone. The next question was sent by Rodrigo Navarro from Santander. He asks about the competitive scenario in Auto, especially from international companies. Let me answer this question, and you can add to my answer, Patricia. We've been seeing a more rational behavior in the first part of the year, and there's a traditional effect in the industry. Usually, you have one or two players who are more aggressive temporarily, but this is not sustained over time because obviously, the different seasons start presenting poor results, and that changes their behavior. Then, of course, they are replaced by another player who becomes more aggressive. Earlier this year, this competitive dynamic seems to have been better, right? Correct. This was a very competitive scenario at the end of last year. This year it has been more stable. Our strategy of products, competitive technology aims at accelerating this growth. This concludes the questions- and- answer session. We will now hand it over to the Porto executives for their closing remarks. Please go ahead. Thank you everyone for your attention, your support, and especially for your interest in Porto. The company is always available if you'd like to go into details about anything you might need. Thank you very much, and have a good day. This concludes the company's conference call. Thank you and have a good day.